Literature DB >> 17868069

Medication errors: an important component of nonadherence to medication in an outpatient population of lung transplant recipients.

S Irani1, P Seba, R Speich, A Boehler.   

Abstract

Data about medication errors in outpatients are limited. Medication errors, defined as discordance between the most recent flow-sheet version, the patient's diary card or the contents of the pill container were assessed systematically after announcement in an outpatient setting of lung transplant recipients by a direct observation approach. A total of 101 patients took a median of 15 (13-17) different drugs and 31 (26-38) pills daily. A total of 2253 doses of drugs were further analyzed. A total of 152 errors were identified resulting in 303 incorrect doses. Lack of keeping a diary card was the only factor significantly associated with a higher rate of incorrect doses (regression coefficient 0.24, p = 0.02). Furthermore, a significant correlation of medication errors with clinical adverse events could be demonstrated. This study shows that medication errors are frequent in a population which has to comply with a complex drug regimen. The need for error control as a basic requirement for drug adherence must be accentuated. Mostly, medication errors seem to occur system-based. Therefore, redundant error control mechanisms and alertness of both the patient and the care-giver should be initiated systematically.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17868069     DOI: 10.1111/j.1600-6143.2007.01962.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  5 in total

1.  Clinical and economic outcomes associated with medication errors in kidney transplantation.

Authors:  David J Taber; Justin R Spivey; Victoria M Tsurutis; Nicole A Pilch; Holly B Meadows; James N Fleming; John W McGillicuddy; Charles F Bratton; Frank A Treiber; Prabhakar K Baliga; Kenneth D Chavin
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-24       Impact factor: 8.237

2.  Lung transplantation for cystic fibrosis.

Authors:  Frederick R Adler; Paul Aurora; David H Barker; Mark L Barr; Laura S Blackwell; Otto H Bosma; Samuel Brown; D R Cox; Judy L Jensen; Geoffrey Kurland; George D Nossent; Alexandra L Quittner; Walter M Robinson; Sandy L Romero; Helen Spencer; Stuart C Sweet; Wim van der Bij; J Vermeulen; Erik A M Verschuuren; Elianne J L E Vrijlandt; William Walsh; Marlyn S Woo; Theodore G Liou
Journal:  Proc Am Thorac Soc       Date:  2009-12

3.  Cost minimization analysis of different growth hormone pen devices based on time-and-motion simulations.

Authors:  Nancy A Nickman; Sandra W Haak; Jaewhan Kim
Journal:  BMC Nurs       Date:  2010-04-08

4.  Improving Transplant Medication Safety Through a Pharmacist-Empowered, Patient-Centered, mHealth-Based Intervention: TRANSAFE Rx Study Protocol.

Authors:  James N Fleming; Frank Treiber; John McGillicuddy; Mulugeta Gebregziabher; David J Taber
Journal:  JMIR Res Protoc       Date:  2018-03-02

5.  Improving Transplant Medication Safety Through a Technology and Pharmacist Intervention (ISTEP): Protocol for a Cluster Randomized Controlled Trial.

Authors:  Casey L Hall; Cory E Fominaya; Mulugeta Gebregziabher; Sherry K Milfred-LaForest; Kelsey M Rife; David J Taber
Journal:  JMIR Res Protoc       Date:  2019-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.